PL2397151T3 - Leczenie powikłań naczyniowych cukrzycy - Google Patents
Leczenie powikłań naczyniowych cukrzycyInfo
- Publication number
- PL2397151T3 PL2397151T3 PL10166637T PL10166637T PL2397151T3 PL 2397151 T3 PL2397151 T3 PL 2397151T3 PL 10166637 T PL10166637 T PL 10166637T PL 10166637 T PL10166637 T PL 10166637T PL 2397151 T3 PL2397151 T3 PL 2397151T3
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- treatment
- vascular complications
- complications
- vascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20100166637 EP2397151B1 (en) | 2010-06-21 | 2010-06-21 | Treatment of vascular complications of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2397151T3 true PL2397151T3 (pl) | 2015-10-30 |
Family
ID=42562567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10166637T PL2397151T3 (pl) | 2010-06-21 | 2010-06-21 | Leczenie powikłań naczyniowych cukrzycy |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9359419B2 (pl) |
| EP (2) | EP2397151B1 (pl) |
| JP (1) | JP5878922B2 (pl) |
| KR (1) | KR101752260B1 (pl) |
| CN (1) | CN102946897B (pl) |
| AU (1) | AU2010355825B9 (pl) |
| BR (1) | BR112012033045A2 (pl) |
| CA (1) | CA2800261C (pl) |
| DK (1) | DK2397151T3 (pl) |
| ES (2) | ES2542227T3 (pl) |
| MX (1) | MX2012014195A (pl) |
| PL (1) | PL2397151T3 (pl) |
| RU (1) | RU2545718C2 (pl) |
| WO (1) | WO2011160664A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT509267A1 (de) * | 2010-01-14 | 2011-07-15 | Apeptico Forschung & Entwicklung Gmbh | Organische verbindungen zur regulierung von vektoriellen ionenkanälen |
| EP2988768B1 (de) * | 2013-04-23 | 2021-03-31 | APEPTICO Forschung und Entwicklung GmbH | Lyophilisat enthaltend ein zyklisches peptid der formel x1-gqretpegaeakpwy-x2 zur behandlung pulmonarer ödeme |
| US20170014472A1 (en) * | 2014-03-04 | 2017-01-19 | Apeptico Forschung Und Entwicklung Gmbh | Attenuation of intrapulmonary inflammation |
| KR102316762B1 (ko) * | 2014-03-18 | 2021-10-26 | 아펩티코 포어슝 운트 엔트빅크룽 게엠베하 | 건조 분말 펩티드 약제 |
| US20250241978A1 (en) | 2020-05-08 | 2025-07-31 | Apeptico Forschung Und Entwicklung Gmbh | Peptide for prevention or treatment of covid-19 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1105152A1 (en) * | 1998-08-14 | 2001-06-13 | Innogenetics N.V. | Tnf-derived peptides for use in treating oedema |
| JP5108515B2 (ja) * | 2004-08-06 | 2012-12-26 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肺サーファクタント及びｔｎｆ由来ペプチドを含有する組成物 |
| EP2009023A1 (en) | 2007-06-04 | 2008-12-31 | Rentschler Beteiligungs GmbH | Novel peptides and their use for the treatment of edema |
| AT507953B1 (de) * | 2009-03-05 | 2011-02-15 | Apeptico Forschung & Entwicklung Gmbh | Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität |
-
2010
- 2010-06-21 DK DK10166637.8T patent/DK2397151T3/en active
- 2010-06-21 PL PL10166637T patent/PL2397151T3/pl unknown
- 2010-06-21 ES ES10166637.8T patent/ES2542227T3/es active Active
- 2010-06-21 EP EP20100166637 patent/EP2397151B1/en active Active
- 2010-10-20 RU RU2013102344/10A patent/RU2545718C2/ru active
- 2010-10-20 MX MX2012014195A patent/MX2012014195A/es not_active Application Discontinuation
- 2010-10-20 WO PCT/EP2010/006408 patent/WO2011160664A1/en not_active Ceased
- 2010-10-20 US US13/805,839 patent/US9359419B2/en active Active
- 2010-10-20 CA CA2800261A patent/CA2800261C/en not_active Expired - Fee Related
- 2010-10-20 CN CN201080067594.8A patent/CN102946897B/zh active Active
- 2010-10-20 EP EP10771018.8A patent/EP2582385B1/en active Active
- 2010-10-20 KR KR1020127031163A patent/KR101752260B1/ko not_active Expired - Fee Related
- 2010-10-20 JP JP2013515709A patent/JP5878922B2/ja active Active
- 2010-10-20 BR BR112012033045A patent/BR112012033045A2/pt not_active IP Right Cessation
- 2010-10-20 ES ES10771018T patent/ES2933405T3/es active Active
- 2010-10-20 AU AU2010355825A patent/AU2010355825B9/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2397151B1 (en) | 2015-04-22 |
| DK2397151T3 (en) | 2015-05-18 |
| AU2010355825A1 (en) | 2013-01-31 |
| CN102946897A (zh) | 2013-02-27 |
| KR20130127359A (ko) | 2013-11-22 |
| EP2582385B1 (en) | 2022-11-16 |
| US20130116200A1 (en) | 2013-05-09 |
| CN102946897B (zh) | 2017-12-12 |
| ES2542227T3 (es) | 2015-08-03 |
| RU2545718C2 (ru) | 2015-04-10 |
| AU2010355825B2 (en) | 2014-10-16 |
| BR112012033045A2 (pt) | 2017-06-20 |
| WO2011160664A1 (en) | 2011-12-29 |
| US9359419B2 (en) | 2016-06-07 |
| CA2800261A1 (en) | 2011-12-29 |
| MX2012014195A (es) | 2013-02-07 |
| CA2800261C (en) | 2018-01-02 |
| KR101752260B1 (ko) | 2017-06-29 |
| ES2933405T3 (es) | 2023-02-08 |
| EP2397151A1 (en) | 2011-12-21 |
| JP5878922B2 (ja) | 2016-03-08 |
| JP2013530970A (ja) | 2013-08-01 |
| EP2582385A1 (en) | 2013-04-24 |
| RU2013102344A (ru) | 2014-07-27 |
| AU2010355825B9 (en) | 2015-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2640443A4 (en) | Vascular treatment device | |
| EP2605827A4 (en) | NON-INVASIVE TREATMENT OF BRONCHOCONSTRICTION | |
| IL225130A (en) | Devices for treating blood vessels defects | |
| ZA201300218B (en) | Treatment of blood cancer | |
| ZA201304280B (en) | Treatment of jak2-mediated conditions | |
| IL220876A0 (en) | Treatment of cardiac conditions | |
| ZA201301601B (en) | Treatment of diseases | |
| IL231836A0 (en) | The vehicle for treating the siege | |
| ZA201208413B (en) | Skin treatment composition | |
| GB201000916D0 (en) | Treatment of biofilms | |
| ZA201207973B (en) | Treatment of gout | |
| IL223289A0 (en) | Treatment of type 2 diabetes | |
| IL206491A0 (en) | Treatment of produce | |
| IL256026B (en) | Treatment methods | |
| PL2397151T3 (pl) | Leczenie powikłań naczyniowych cukrzycy | |
| ZA201208568B (en) | Skin treatment composition | |
| ZA201207496B (en) | Treatment of chicory | |
| PL2460509T3 (pl) | Kompozycja do leczenia brodawek | |
| ZA201404738B (en) | Treatment of type i and type ii diabetes | |
| ZA201207497B (en) | Treatment of chicory | |
| GB201010638D0 (en) | Composition for treatment of skin | |
| AU2010902914A0 (en) | Treatment of diabetes | |
| GB201007977D0 (en) | Treatment of cardiovascular disease | |
| GB201002500D0 (en) | Treatment of burns | |
| GB201009194D0 (en) | Treatment of pain |